A research carried out by a private company, GW Pharmaceuticals, will involve an aerosol mixture of pure cannabis.

GW Pharmaceuticals spokesman, Mark Rogerson explains: "We are producing an extract from the whole plants, which is a bit like syrup. It will be delivered to the patient in the form of a heated vapour because cannabis needs heat to work."

"Patients will use a very clever device rather similar to the nebulisers used by people with asthma."

Source: Daily Mail, UK
Pub Date : January 19 1999